Hannah McKenney, is a bioengineer and medtech entrepreneur with a passion for developing medtech companies that couple improving patient care along with improving healthcare economics. Hannah has extensive experience in start-up company development as a founder, board member, and executive roles. Hannah earned her Masters of Engineering in Bioengineering at Rice University and worked as a R&D Engineer at Johnson & Johnson and Medtronic within their surgical device innovation teams. She also established the Surgical Innovation program for MD Anderson Cancer Center's Division of Surgery, bringing early stage technologies through prototypes, cadaver studies, animal studies and clinical implementation. She earned her BS in Biomedical Engineering from Rice University with a focus in mechanical engineering.
Currently, Hannah serves as the CEO and Cofounder of Starling Medical where they are developing the world's first at-home urine diagnostic patient monitoring platform that can seamlessly integrate into anybody’s daily bathroom routine. Through passive urine screening, Starling proactively connects patients to care to help prevent hospitalizations from recurrent urinary tract infections and is sensitive to numerous other chronic conditions like diabetes, kidney disease, cancer, and dozens more. Starling was selected for the world's most prestigious accelerator Y-combinator, been featured in TechCrunch three times, named a 2023 CB Insights Top 150 Digital Health company out of 13,000 potential digital health companies, won the people's choice award at the ATA 2023 Innovation Pitch Competition, won 1st place at the Texas A&M New Ventures Competition and Rice Napier Launch Challenge, and most recently won AARPs AgeTech pitch event at HLTH 2023.
